Genentech
1 DNA Way
South San Francisco, California 94080-4990
(650) 225-1000
www.gene.com
|
|
Genentech invites stockholders, security analysts, representatives of
portfolio management firms and other interested parties to contact:
Katherine A. Littrell, Ph.D., R.N.
Senior Director, Investor Relations
Phone: (650) 225-1034
Fax: (650) 225-8326
Email: investor.relations@gene.com
|
Genentech is listed on the New York Stock Exchange under the symbol DNA.
|
|
You may obtain a free copy of our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K and amendments to those reports on the day of filing with the Securities and Exchange Commission on our website at http://www.gene.com, by calling the Genentech Investor
Relations Department at (650) 225-4150, or by sending an email message to investor.relations@gene.com. You may also direct requests for literature to our literature request line at (800) 488-6519.
|
|
Communications concerning transfer requirements, lost certificates and change of address should be directed to Genentech's stock transfer agent:
Computershare Investor Centre
c/o Computershare Trust Company, N.A.
P.O. Box 43078
Providence, RI 02940-3078 USA
Attention: Shareholder Inquiries
(800) 733-5001
www.computershare.com
|
|
Ernst & Young LLP
Palo Alto, California
|
Annual Meeting
The annual meeting of stockholders will be held at 10:00 a.m.
Pacific Daylight Time on April 20, 2007, at the Clarion Hotel, 401
East Millbrae Avenue, Millbrae, California. Detailed information
about the meeting is contained in the Notice of Annual Meeting
and Proxy Statement sent to each stockholder of record as of
February 20, 2007. |
|
Genentech has included as Exhibits 31.1 and 31.2 to its 2006 Annual
Report on Form 10-K filed with the Securities and Exchange Commission
certifications of the chief executive officer and chief financial
officer of Genentech pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002, and Genentech filed with the New York Stock Exchange
the Annual CEO Certification as required by Section 303A.12(a) of
the New York Stock Exchange Listed Company Manual.
|
